HOME / NEWS & PERSPECTIVES / Point-of-Care

News, stories & opinions for the world’s healthtech innovators.

Point-of-Care

Decentralized Manufacturing  for C&GT. Key takeaways from our expert panel at Advanced Therapies Week 2025

Perspectives from expert panel: Decentralized manufacturing for cell & gene therapy

Decentralized Manufacturing remains a hot topic in the Cell and Gene Therapy industry. After chairing a panel of industry experts for Advanced Therapies Week in a discussion on how decentralization could potentially revolutionize the manufacturing approach for cell and gene therapies, I bring to you 5 key takeaways from the session.

BRIAN HANRAHAN

VP Cell and Gene Therapy

Posted March 2025

in COMMERCIALIZATION

Markets.

Diagnostics

Life Sciences

Cell & Gene Therapy

Medical Devices

Topics.

Opinion

Commercialization

Awards

Digital Health

Point-of-Care

Ventures

Corporate

Software

Innovation

COVID-19

People & Culture

Entrepreneurship

Manufacturing

Medical Devices

Fertility

Lumos Diagnostics

Sign up for the Perspectives newsletter:

Truvian Health raises $74M - in part to secure FDA clearance for its blood testing platform

Truvian Health recently announced an injection of USD$74 million of capital to be used in part to secure US Food and Drug Administration (FDA) clearance for its blood testing platform.

Winning strategies for developing diagnostic instruments

PI’s team of experts has been developing instruments spanning molecular, immunoassay, hematology, clinical chemistry, microbiology and more, for several decades. While every situation is different, we asked four of our key experts to share some simple strategies that allow you to achieve commercial success with your new product development.

Point-of-care manufacturing for cell and gene therapies – the debate is heating up

Cell and gene therapies show great promise as cancer treatments. However, patient access, both geographically and financially, is a major challenge to widespread adoption. In order to provide therapies to more patients that desperately need them, the industry is exploring a range of options including point-of-care (POC) manufacturing.

Democratization of healthcare and considerations for the at-home POC market

The demand for at-home patient monitoring and greater personal ownership of healthcare continues to grow, as do the opportunities for emerging players in this space.

PI's NeoSync™ connectivity solution wins Good Design Award

PI’s Digital team picked up a prestigious Good Design Award Winner Accolade in the Digital Design category at the 2022 Australian Good Design Awards, for its NeoSync: Transforming Point-of-Care Testing connectivity solution.

Medical device vendors no longer left in the dark thanks to NeoSync™ connectivity solution

Until now, many device vendors have had limited, if any, remote visibility into their products.

A diagram showing point-o-care devices connected to EHRs

How should you add connectivity to your point-of-care device – build or buy?

When developing connectivity for your point-of-care diagnostic product, there are two main routes – build or buy. How do you know what’s right for you?

Stuart Elliott getting an rapid COVID test at PI

PI introduces voluntary COVID-19 rapid testing to help keep on-site staff safe

Planet Innovation is taking another step in providing a safe working environment for on-site staff by introducing voluntary COVID-19 rapid antigen testing at its Australian facility.

COVID has lit a fire under diagnostic testing – here is what point-of-care companies must do to step up in time

As demand for diagnostic and point-of-care (POC) testing grows, new products are coming to life faster than ever. Ben Druce, VP Strategic Design, shares insights from an expert panel discussion he hosted at the MD&M and BIOMEDigital event.

Market disruption: blood testing beyond the status quo

Experts from Truvian, Blue Ox Healthcare Partners, the University of Chicago and PI discuss the potential impact of real-time point-of-care blood testing.

How to build a regulated remote patient monitoring product that clinicians and patients will actually use

With the COVID-19 pandemic shining a light on the benefits of telehealth, there has never been a better time to be in remote patient monitoring (RPM). But if you’re going to be successful, you need to win over your two main users: patients and clinicians.

Lumos's Leelu Reader wins Good Design Award

PI and Lumos pick up top Medical Design and Engineering Awards for rapid diagnostic development platform

Planet Innovation and Lumos Diagnostics have won two awards at the 2020 Good Design Awards, including a Good Design Award Gold accolade for Lumos’s Leelu Reader.

Truvian's point-of-care blood testing device

Planet Innovation develops beta units of Truvian’s automated point-of-care blood testing system

PI has partnered with Truvian, a healthcare company at the intersection of diagnostics and consumer technology, to develop a new point-of-care blood testing device to make routine health tests more convenient, affordable and actionable for consumers.

PI and Lumos work with Victorian Government to pilot FebriDx as acute respiratory infection patient triage tool in response to COVID-19 pandemic

We are seeking GPs and other healthcare professionals in Victoria, Australia to pilot a new TGA-approved point-of-care test to help differentiate patients with viral from bacterial acute respiratory tract infections.

Lumos Diagnostics and RPS Diagnostics merge

Lumos Diagnostics merges with RPS Diagnostics

Lumos Diagnostics and RPS Diagnostics have merged to create a full-service point-of-care diagnostic development company and support the international commercialization of FebriDx.

Lumos Diagnostics to supply customized Leelu Readers for new California-based partner

Lumos Diagnostics is expanding its global footprint after agreeing an ongoing manufacturing deal for a customized lateral flow reader with a California-based life sciences company.

PI launches Lumos: A unique, complete solution provider for rapid point-of-care diagnostics

Lumos Diagnostics develops custom products for its partners using a unique combination of integrated assay and engineering capability paired with its proven reader optical technologies.

Nplex point-of-care diagnostic platform to deliver connected solution

Planet Innovation’s PoC (Point-of-Care) diagnostic platform, Nplex, will benefit from further investment to develop a cloud-connected medical counter-measures device, for the rapid detection of infectious diseases.